https://www.selleckchem.com/pr....oducts/z-4-hydroxyta
Abnormal liver chemistries are common findings in patients with Coronavirus Disease 2019 (COVID-19). However, the association of these abnormalities with the severity of COVID-19 and clinical outcomes is poorly understood. We aimed to assess the prevalence of elevated liver chemistries in hospitalized patients with COVID-19 and compare the serum liver chemistries to predict the severity and in-hospital mortality. This retrospective, observational study included 3380 patients with COVID-19 who were hospitalized in the Johns
Curtir
Comentario
Compartilhar
